newsfilter
← Latest News
PR Newswire·

Clinical Trial Milestones, Investments in aQIVc and sa-mRNA Influenza Vaccines and New Strategic Collaborations Among the Highlights from CSL R&D Day

MELBOURNE, Australia and KING OF PRUSSIA, Pa., Oct. 18, 2021 /PRNewswire/ -- During its annual R&D investment briefing earlier today, CSL Limited ((ASX:CSL, OTC:CSLLY) highlighted progress from its novel pipeline that spans six therapeutic areas (immunol